On-demand Educational Activity Addressing TREATMENT of C Difficile INFECTION and PREVENTION of RECURRENCE

Share Article

Experts in the treatment of C Difficile Infection (CDI) describe treatment options and discuss a potential approach to prevent recurrent infection, which may portend a corresponding reduction in rehospitalization due to CDI.

News Image
“Preventing recurrent CDI in patients is a challenge, and a significant burden on our healthcare system,” says Gerding.

To coincide with the ID Week Conference taking place here, a panel of experts are informing their colleagues and other providers about an important educational program addressing opportunities to diagnose, treat and potentially prevent recurrent C difficile infection (CDI). The activity, which is available on-demand via http://www.MyCME.com, is based on a symposium held during ASM Microbe earlier this year in Boston.

“More Than A Gut Reaction: Effective Strategies to Treat and Prevent Recurrent C difficile Infection (CDI),” focuses on the growing burden of CDI, current and emerging treatment options, and considerations for preventing recurrent infection and re-hospitalization.

Ciarán P. Kelly, MD of Harvard Medical School is the moderator. Participating faculty include: Dale N. Gerding, MD (Loyola University Chicago Stritch School of Medicine), Carlene A. Muto, MD, MS (University of Pittsburgh Medical Center) and John Segreti, MD (Rush Medical College).

“The symposium held during ASM Microbe was a great success, and now we’ve made the education available on-demand for providers who care for patients with CDI,” says Daniel Guinee, Executive Vice President at ASiM. “Providers are able to access a CME-CE accredited activity through the MyCME site, and learn from our expert faculty about emerging options that may help address the burden of CDI, and hopefully prevent recurrent infection.”

In a presentation focusing on emerging options, Dr. Gerding pointed out that the recent recommendation for approval of Bezlotoxumab by the U.S. Food and Drug Administration Advisory Committee may be an important advance for preventing recurrent illness and re-hospitalization due to CDI. The FDA is expected to decide soon whether to approve the agent.

“Preventing recurrent CDI in patients is a challenge, and a significant burden on our healthcare system,” says Gerding. “We need new means to address the problem, and fortunately, there are a number of programs being researched at present. Let’s hope some find their way into the patient care arsenal soon.” A synopsis of the research being conducted is included in the educational program.

Healthcare providers are able to access the activity by clicking on this link –
http://www.mycme.com/more-than-a-gut-reaction-effective-strategies-to-treat-and-prevent-recurrent-c-difficile-infection/activity/4215/

About Rush University Medical Center
Rush University Medical Center (RUMC) is a 664-bed hospital, a research institution, and a university specializing in the health professions. While Rush Medical College is older than its home city of Chicago, receiving its charter in 1837, the present RUMC was formally established in 1972. Across this 175-year history, Rush has incorporated continuing education of health professionals into its mission.

About Rush Office of Interprofessional Continuing Education (IPCE)
The office of Interprofessional Continuing Education (IPCE) was established by Rush in 2013, reflecting the broader institutional commitment to interprofessional, team-based practice. IPCE works with faculty and clinicians to develop accredited continuing education activities in Medicine, Nursing, Nutrition, Occupational therapy, Psychology, Respiratory therapy, Social work and Speech-audiology. Learning opportunities range from traditional live lectures to interactive case studies and Web-based courses.

About ASiM
Since 1999, ASiM has served as a logistical partner on hundreds of CME activities and educational initiatives. These activities provide continuing education credits for physicians, nurses, and pharmacists in a wide range of therapeutic categories through funding provided by pharmaceutical, biotech, medical device, and consumer health companies. Live activities include strategic integration and tactical execution of satellite symposia at national and international conferences, stand-alone symposia, regional and local meetings, grand rounds, closed roundtables and clinical educator “train the provider” campaigns. Enduring material formats include print monographs/newsletters and interactive web-based activities. As a full-service medical education and publishing entity, ASiM is a recognized partner in optimal educational design and innovative delivery systems. To learn more about ASiM, visit http://www.ASiMCME.com.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Daniel Guinee
ASiM
+1 (908) 415-9012
Email >
Visit website